Mimedx (MDXG) Inventory Average (2011 - 2026)
Mimedx recorded quarterly Inventory Average of $25.8 million in Q1 2026, down 0.53% quarter-over-quarter from $25.9 million in Q4 2025, and up 7.71% year-over-year from $23.9 million in Q1 2025.
Mimedx's Inventory Average history runs 15 years deep, the most recent figure standing at $25.8 million for Q1 2026.
- In Q1 2026, Inventory Average rose 7.71% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $25.8 million (up 7.71% YoY), while the FY2025 annual figure was $24.6 million, up 9.63% from the prior year.
- Inventory Average came in at $25.8 million for Q1 2026 at Mimedx, down from $25.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $25.9 million in Q4 2025 to a low of $12.3 million in Q1 2022.
- A 5-year average of $20.1 million and a median of $22.7 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average jumped 63.34% in 2024 and decreased 1.11% in 2025, its largest moves.
- Mimedx's Inventory Average stood at $13.6 million in 2022, then soared by 47.61% to $20.0 million in 2023, then increased by 19.87% to $24.0 million in 2024, then climbed by 7.88% to $25.9 million in 2025, then retreated by 0.53% to $25.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $25.8 million, $25.9 million, and $25.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 25.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.78 Mn |
| Dec 31, 2025 | 25.92 Mn |
| Sep 30, 2025 | 25.70 Mn |
| Jun 30, 2025 | 24.48 Mn |
| Mar 31, 2025 | 23.94 Mn |
| Dec 31, 2024 | 24.03 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 24.76 Mn |
| Mar 31, 2024 | 22.74 Mn |
| Dec 31, 2023 | 20.04 Mn |
| Sep 30, 2023 | 17.94 Mn |
| Jun 30, 2023 | 15.74 Mn |
| Mar 31, 2023 | 13.92 Mn |
| Dec 31, 2022 | 13.58 Mn |
| Sep 30, 2022 | 13.68 Mn |
| Jun 30, 2022 | 13.28 Mn |
| Mar 31, 2022 | 12.28 Mn |
| Dec 31, 2021 | 11.29 Mn |
| Sep 30, 2021 | 10.67 Mn |
| Jun 30, 2021 | 10.86 Mn |
| Mar 31, 2021 | 10.97 Mn |
| Dec 31, 2020 | 10.69 Mn |
| Sep 30, 2020 | 10.79 Mn |
| Jun 30, 2020 | 9.91 Mn |
| Mar 31, 2020 | 9.18 Mn |
| Dec 31, 2019 | 10.57 Mn |
| Sep 30, 2019 | 13.49 Mn |
| Jun 30, 2019 | 15.69 Mn |
| Mar 31, 2019 | 16.21 Mn |
| Dec 31, 2017 | 9.94 Mn |
| Sep 30, 2017 | 12.73 Mn |
| Jun 30, 2017 | 15.54 Mn |
| Mar 31, 2017 | 15.96 Mn |
| Dec 31, 2016 | 17.09 Mn |
| Sep 30, 2016 | 17.76 Mn |
| Jun 30, 2016 | 17.59 Mn |
| Mar 31, 2016 | 12.71 Mn |
| Dec 31, 2015 | 6.56 Mn |
| Sep 30, 2015 | 4.76 Mn |
| Jun 30, 2015 | 4.05 Mn |
| Mar 31, 2015 | 4.69 Mn |
| Dec 31, 2014 | 4.94 Mn |
| Sep 30, 2014 | 4.48 Mn |
| Jun 30, 2014 | 3.93 Mn |
| Mar 31, 2014 | 3.76 Mn |
| Dec 31, 2013 | 4.21 Mn |
| Sep 30, 2013 | 4.38 Mn |
| Jun 30, 2013 | 4.18 Mn |
| Mar 31, 2013 | 3.58 Mn |
| Dec 31, 2012 | 2.44 Mn |
| Sep 30, 2012 | 1.44 Mn |
| Jun 30, 2012 | 906,155.00 |
| Mar 31, 2012 | 754,059.00 |
| Dec 31, 2011 | 660,870.50 |
| Sep 30, 2011 | 585,528.00 |